4.7 Article

Association of computed tomography-based body composition with survival in metastatic renal cancer patient received immunotherapy: a multicenter, retrospective study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Editorial Material Urology & Nephrology

The 2021 Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibitor-based Combination Therapies for Treatment-naive Metastatic Clear-cell Renal Cell Carcinoma Are Standard of Care

Jens Bedke et al.

Summary: The recent trials have shown improved survival benefits with immune checkpoint inhibitor combinations in advanced kidney cancer, particularly with lenvatinib plus pembrolizumab, cabozantinib plus nivolumab, axitinib plus pembrolizumab, and ipilimumab plus nivolumab. These combination therapies are recommended as first-line treatments for advanced kidney cancer.

EUROPEAN UROLOGY (2021)

Article Oncology

Visceral-to-subcutaneous fat ratio independently predicts the prognosis of locally advanced gastric cancer-highlighting the role of adiponectin receptors and PPARα, β/δ, (sic)

Yu-Ching Lin et al.

Summary: The study found that SAT and VAT play opposite roles in the prognosis of advanced gastric cancer, possibly through modulation of adiponectin receptors and PPARs. Preoperative CTBC can help clinicians tailor individualized adjuvant therapy and/or nutritional support.
Article Oncology

Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors

Dylan J. Martini et al.

Summary: This study found that body composition variables are prognostic and predictive of clinical outcomes in ICI-treated patients with UC, especially for high-risk patients with worse clinical outcomes. The results suggest that radiographic measures of body composition should be considered for inclusion in updated prognostic models for patients with urothelial carcinoma treated with immunotherapy.

ONCOLOGIST (2021)

Review Immunology

Re-Evaluating the Effects of Obesity on Cancer Immunotherapy Outcomes in Renal Cancer: What Do We Really Know?

Kristine Farag et al.

Summary: The article discusses the effects of obesity on the immune system and cancer immunotherapy outcomes, with a specific focus on renal cancer. While some studies suggest detrimental effects of obesity on anti-tumor immunity, others have found opposite results. It is necessary to further study the relationship between obesity and cancer immunotherapy outcomes in different patient populations.

FRONTIERS IN IMMUNOLOGY (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Prognostic value of anthropometric measures extracted from whole-body CT using deep learning in patients with non-small-cell lung cancer

Paul Blanc-Durand et al.

EUROPEAN RADIOLOGY (2020)

Review Urology & Nephrology

Checkpoint inhibitor immunotherapy in kidney cancer

Wenxin Xu et al.

NATURE REVIEWS UROLOGY (2020)

Article Oncology

Impact of body composition on outcomes from anti-PD1+/- anti-CTLA-4 treatment in melanoma

Arissa C. Young et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

Article Biochemistry & Molecular Biology

Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity

Alison E. Ringel et al.

Article Oncology

Obesity diminishes response to PD-1-based immunotherapies in renal cancer

Shannon K. Boi et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

Article Biochemistry & Molecular Biology

Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade

Ziming Wang et al.

NATURE MEDICINE (2019)

Article Multidisciplinary Sciences

TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis

Daniele V. F. Tauriello et al.

NATURE (2018)

Article Multidisciplinary Sciences

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells

Sanjeev Mariathasan et al.

NATURE (2018)

Article Oncology

Subcutaneous adiposity is an independent predictor of mortality in cancer patients

Maryam Ebadi et al.

BRITISH JOURNAL OF CANCER (2017)

Letter Oncology

The Obesity Paradox in Cancer-Moving beyond BMI-Response

Shlomit Strulov Shachar et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)

Article Medicine, General & Internal

Body-Mass Index in 2.3 Million Adolescents and Cardiovascular Death in Adulthood

Gilad Twig et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)